AUCTORES
Globalize your Research
Case Report | DOI: https://doi.org/10.31579/2690-4861/229
1 Department of High risk pregnancy and Perinatology.
2 Department of Obstetrics and Gynaecology.
3 Department of Hematology.
4 Department of Rheumatology, KIMS Health, Trivandrum.
*Corresponding Author: Nina Navakumar, Department of High risk pregnancy and Perinatology.
Citation: Navakumar N, Retnamma V, Rafeekha P, Ranganayaki V, Thomas M, Mahendran B . (2022) Evans Syndrome in pregnancy – Case report of two successful pregnancies in a woman; Review of Literature. A Case Report. International Journal of Clinical Case Reports and Reviews. 11(4); DOI: 10.31579/2690-4861/229
Copyright: © 2022 Nina Navakumar, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Received: 20 May 2022 | Accepted: 25 June 2022 | Published: 30 June 2022
Keywords: evans syndrome; autoimmune haemolytic anaemia; immune thrombocytopenia
Evans syndrome is a rare autoimmune disease in which an individual's antibodies attacks the body's own red Autoimmune blood cells and platelets. There is a coexistence of Immune thrombocytopenia (ITP) with haemolytic anaemia (AIHA) with immune neutropenia sometimes in the absence of known underlying etiology.1Association of Evans syndrome with pregnancy is very rare, and only a few cases have been published in medical literature. No definite treatment protocols are defined. Treatment options during pregnancy are further limited due to concerns of teratogenic effect of pharmacological agents. Evans syndrome can be diagnosed with a full blood count film and a direct Coombs test. We describe here a rare case that was diagnosed as secondary Evans syndrome with SLE complicating pregnancy that resulted in two live births in a woman. We have also briefly discussed the pathophysiology, clinical features, diagnosis and the possible treatment options and outcome of Evans syndrome in pregnancy
Evans syndrome is an uncommon condition characterized by Immune thrombocytopenia (ITP) and Autoimmune haemolytic anaemia (AIHA) that can coexist or one follows the other and it is diagnosed with a positive Direct antiglobulin test (DAT). The underlying aetiology is unknown. It runs a chronic course with frequent remissions and relapses 1. It has a more benign state during pregnancy than in non-pregnant state. The foetal outcome may become less favourable as it is affected by transplacental passage of antibodies. It is suggested that Evans syndrome may be a stage of a broader spectrum, generalized immune dysregulation due to high incidence of quantitative serum immunoglobulin abnormalities, lymphoid hyperplasia and associated systemic manifestations.
Dr. Robert Evans was the first one to describe the syndrome in 1951, and the first case of its occurrence during pregnancy was published in 1966. Since then very few cases of Evans syndrome during pregnancy have been reported.
Thirty year old second gravida ; case of Evans syndrome (Gravida 2 Para 1 Live 1 ) booked at 26 weeks gestation managed with a multi-disciplinary team consisting of senior Obstetrician, Haematologist ,Rheumatologist and Maternal – fetal medicine specialist .
She had easy bruising and bleeding gums at 16 years of age with menorrhagia which on investigation swas found to have severe anemia and thrombocytopenia (platelet count of 13000 cells/mm3) which was corrected with multiple transfusion of packed red cell and platelet concentrate. On further evaluation her DAT and positive anti SS-A Ab (autoimmune association). Bone marrow study showed megakaryocytes proliferated with normal hypo lobulated and micro megakaryocytes consistent with ITP. She was managed with pulse dose of intravenous methylprednisolone 1 gm for three days followed by oral Prednisolone 60 mg which improved her Hb and platelet count. She was on irregular follow up.
She was booked with us at 25 weeks in her first pregnancy. She had recurrent episodes of syncope, seizure like activity and loss of consciousness at 26 weeks of gestation for which neurology evaluation was done and found to have a normal electroencephalogram. She was started on oral levetiracetam. At booking haemoglobin was 8.8 gm g/dl, TC of 12000 cells/mm3 and platelet count of 38000 cells/mm3 . Red blood cell indices and serum ferritin were low; peripheral smear showed microcytic hypochromic anaemia with thrombocytopenia. DCT was
negative with a normal lactate dehydrogenase ( LDH ) with positive anti SS-A Ab . Antiphospholipid ( APLA ) work up showed positive lupus anticoagulant ( LA ) with prolonged activated partial thromboplastin time ( APTT )
She was managed as iron deficiency anemia and secondary ITP . She was started on oral iron therapy. Her haemoglobin improved to 12.3 gm/dl with a platelet count of 97000 cells / mm. She developed purpuric rash at 36 weeks with a platelet count of 19000 cells/ mm3 . She was started on oral prednisolone 60 mg od and platelet improved to 38000 cells / mm3. She had induction of labor at 39 weeks of gestation which ended in an emergency LSCS for failed induction with male baby of weight 2.88 kg . She was lost to follow up postpartum .Baby ‘s haemo globin was 15.1 gm / dl TC being 10000 cell/mm3 with Platelet count of 263 cell/ mm.
In her second pregnancy she was booked at 26 weeks of gestation . Her lab parameters(Table:1) were suggestive of autoimmune hemolytic anemia ,iron deficiency anemia and thrombocytopenia and was started on oral prednisolone 40 mg , oral iron therapy and folic acid . She was lost to follow up and discontinued steroid herself.
She reported back at 38 weeks of gestation with pain abdomen and decreased fetal movements. She was hemodynamically stable and ultrasound examination showed fetal growth restriction (3rd centile) with oligamnios. Middle cerebral artery peak systolic velocity ( MCA PSV ) was normal and there was no evidence of fetal anemia. Hb was 10.8 gm /dl with a platelet count of 26000 cells / mm3 and was started on oral prednisolone Mean while she had one episode of tonic clonic convulsion with frothing from mouth and up rolling of eyes which was controlled with IV levetiracetam 1 gm and loading dose of magnesium sulphate 4 gm IV followed by 1g / hour. This episode was followed by fetal bradycardia up to 60 for 5 minutes. She had category 1 LSCS under general anaesthesia and delivered a male baby of weight 1.82 kg with normal Apgar score. Her blood pressure during the intra operative period was 160/110 mm of Hg which was bought down with intravenous labetalol. She was given 4 units of random donor platelet transfusion one unit of single donor platelet transfusion
She was given tranexamic acid 1 gm IV 3 doses every 8 hours , Hydrocortisone 100 mg IV 3 doses every 8 hours as stress dose intraoperatively and postpartum. She was electively ventilated post operatively until neuroimaging and was extubated on day1. EEG showed generalized interictal epileptiform discharge with normal magnetic resonance imaging brain ( MRI ) with magnetic resonance venogram ( MRV ). Maternal echo cardiogram and arterial blood gas were normal. She was continued on IV levetiracetam 500 mg IV twice daily and IV magnesium sulphate for 24 hours postpartum. Seizure could be primary seizure disorder with differential diagnosis of eclampsia or neurological manifestation of autoimmune disease. Her immediate platelet count was 34000 cells / mm3 ;hence low molecular weight heparin was not started but intermittent pneumatic compression stockings were given for thromboprophylaxis.
On second postoperative day her BP was 120/80 mm of Hg , Hb - 9.7 g/ dl , Platelet – 70000 cells/ mm3 and started on Enoxaparin 40 mg s/c once daily. Rheumatologist started her on Tacrolimus 0.5 mg two times a day , hydroxychloroquine 200 mg once daily . On fifth postoperative day she was discharged on Tacrolimus 0.5 mg two times a day , levetiracetam, oral prednisolone, hydroxy chloroquine. She was reviewed after 2 weeks with haemoglobin of 12.5 gm / dl and platelet count of 18000 cell/ mm 3 and continued on prednisolone.
Neonate had a Hb of 16.6 gm / dl , TC – 7800 cells/mm3 and platelet of 27000 cell / mm3.Baby was transfused with one unit of random donor platelet which improved the platelet to 1.54 lakhs cell / mm3. Neurosonogram of the baby was normal 15-33% risk of venous thrombo embolism. Thrombocytopaenia is due to antibodies usually IgG against platelet surface glycoproteins, especially Ib/IX, IIb/IIIa.
Laboratory studies that may be considered include the following:
Complete blood count (CBC) , Reticulocyte count , Peripheral blood smear , Coombs test (direct antiglobulin test) , Tests for antierythrocyte, antineutrophil, and antiplatelet antibodies , Lupus antibody (lupus like inhibitor) and antinuclear antibody (ANA) tests. Thus, autoantibody testing for platelets and granulocytes may be positive but a negative result does not exclude the diagnosis and routine testing at presentation may not be helpful. [4]
Features of haemolysis should be sought including a raised reticulocyte count, unconjugated hyperbilirubinaemia and decreased haptoglobins. The direct antiglobulin test (DAT) is almost invariably positive (although often weakly so), even in the absence of haemolytic anaemia, and may be positive for IgG and/or complement (C3) 5. Bone marrow aspiration helps reveal aplastic anemia or an infiltrative disorder. It is usually indicated for excluding infiltrative processes in patients who present with pancytopenia. Otherwise it is not usually helpful as the findings are nonspecific and may be normal or show trilineage increased cellularity. 1It is advisable to measure serum immunoglobulins and immunoglobulin subclasses in all patients; not only to exclude differential diagnoses, such as common variable immunodeficiency (CVID) and IgA deficiency, which have been reported to develop acquired cytopenias, and also as a baseline prior to immunomodulatory therapy. The most important differential diagnosis is ALPS ( auto immune lympho prolifarive syndrome . Therefore measurement of peripheral blood T-cell subsets by flow cytometry is essential in all cases of Evans syndrome. The presence of double negative (CD4) / CD8) , CD3+ , TCRab+ ) T cells has been found to be the most sensitive first-line screening test for ALPS (and allows differentiation from cases of Evans syndrome [5].
ES during pregnancy is not frequent and usually the diagnosis is established previously. Other causes of thrombocytopaenia has to be ruled out .The main differential diagnoses in this circumstance are HELLP syndrome, thrombotic thrombocytopenic purpura and haemolytic uremic syndrome. Therefore, before accepting a diagnosis of Evans syndrome other causes of acquired immune cytopenia should be excluded, in particular SLE, IgA deficiency, COVID, acquired immunodeficiency syndrome and ALPS as all require different management. Other conditions that cause concurrent haemolytic anaemia and thrombocytopenia and may mimic Evans syndrome include paroxysmal nocturnal haemoglobinuria (PNH) [1]
Multi displinary care which involves Obstetrician ,maternal-fetal medicine specialist , Haematologist , Rheumatologist Critical care specialist , Neonatologist and Anaesthetist. ICU care and adequate blood bank facilities should be there. Secondary Evans syndrome due to autoimmune etiology warrants ecospirin for preeclampsia prophylaxis but have to consider associated ITP and severity of thrombocytopenia while starting it in pregnancy. Steroid such as prednisone is the initial treatment of choice for Evans syndrome. Intra venous immuno globulin,chemotherapeutic agents, splenectomy and plasmapheresis are other therapies for refractory cases. It is our practice to use steroids as initial therapy and to add IVIG if patients fail to respond or are steroid dependent. Most of pateints respond to combination of steroids and immuno globulin which is the first line therapy1. But relapses are frequent with first line therapy.Glucocorticoids decrease the destruction of platelets and red blood cells (RBCs) by reducing sequestration. Immuno globulin act by decreasing the level of antibodies crossing the placenta and decreasing maternal IgG antibodies by down regulation with a reduction of these in fetal circulation. Intravenous immunoglobulin for those patients for whom steroids are ineffective or who require unacceptably high doses to remain in remission or in whom toxicity results, the most commonly used first-line therapy is IVIG.1 IVIG is for ES thrombocytopenia but are not recommended for ES-anemia. Second line agents are immunosuppressive agents such as azathioprine and cyclosporine.Azathioprine is used in both ES-thrombocytopenia and ES anaemia .It is maintained in case of ES prior to pregnancy due to its long delay of action, of poor interest in case of ES emerging during pregnancy6. Azathioprine has proven to be safe during pregnancy and lactation.
Second line agents outside pregnancy include immunosuppressive agents Cyclosporin, Mycophenolate mofetil, Vincristine Cyclophosphamide Danazol ,splenectomy, therapeutic antibodies like Rituximab , Alemtuzumab. Other uncommonly used modalities are Azathioprine Antilymphocyte globulin 6-thioguanine Tacrolimus Anti-D and Plasmapheresis in very severe and refractory cases stem cell transplantation (SCT) offers the only chance of long-term cure. The limited data available suggest that allogeneic SCT may be superior to autologous SCT but both carry risks of severe morbidity and of transplant related mortality.
In the acute setting, blood and/or platelet transfusions may also be required to alleviate symptoms although their use should be minimised. Splenectomy may also be considered a second-line treatment1. Splenectomy is done for both ES-anemia and thrombocytopenia. Laparoscopic splenectomy is considered acceptable in patients with refractory Evans syndrome after the second trimester of pregnancy. Splenectomy is useful as it entails removing a primary site of antibody production and sequestrations. But long term remissions are less compared with uncomplicated ITP1 .With Plasmapheresis, antibody bound platelets and RBCs are replaced with unbound cells without affecting the IgG concentration. On the other hand chemotherapeutic agents inhibit the immune system thus affecting anti body production especially Azathioprine [7] . Azathioprine or splenectomy are used exclusively in refractory third trimester cases. Forceps or vacuum extractor delivery is contraindicated; cesarean delivery only if preceded by obstetric recommendation [3].
During pregnancy there are no reliable parameters that can predict fetal platelet status or fetal outcome, and even maternal response to treatment may not end in a desired outcome. The only outcome prediction parameter is the patient's previous history of neonatal outcome8,9. The platelet antibody level should be measured in these cases as the platelet antibodies can pass through the placenta and bind with the fetal platelets, resulting in fetal thrombocytopenia.
In general, pregnant women with ES have a good outcome if appropriate treatment is administered .
The diagnosis of Evans syndrome in pregnant women does not affect the mode of delivery, which depends on obstetric indications. As in ITP vacuum extractor, FBS , fetal scalp electrode for fetal monitoring in active labor are contraindicated; cesarean delivery only if preceded by obstetric recommendation3. Patients with ES requires cautious use of regional anaesthesia to balance patient desire for pain control with bleeding concerns. A collaborative multidisciplinary approach including consultation with anesthetist is needed to develop an institutional protocol for pre-anesthesia evaluation.
Warm AIHA is associated with a 15-33% risk of venous thromboembolism (VTE). VTEs are associated with IVIG, with added risk conferred to pregnancy and the postpartum period. The use of prophylactic anticoagulation after discharge and systematic screening for VTE for patients with ES is an area that may benefit from further studies. The relationship of respiratory infections to ES as potential triggers or as adverse risks from treatment should be further delineated.
Warm AIHA is associated with a 15-33% risk of venous thromboembolism (VTE). VTEs are associated with IVIG, with added risk conferred to pregnancy and the postpartum period. The use of prophylactic anticoagulation after discharge and systematic screening for VTE for patients with ES is an area that may benefit from further studies. The relationship of respiratory infections to ES as potential triggers or as adverse risks from treatment should be further delineated.
In a literature search of cases of ES in pregnancy, a 2010 review article identified a total of 14 pregnancies, with data available for 9 cases 10.Case reports of an additional 5 cases have since been published 10.Of these 14 pregnancies for which data is available, 5 were complicated by preeclampsia, 3 by postpartum hemorrhage, and 1 with placental abruption. Two pregnancies were associated with stillbirth, one of these with a fetal intracranial subdural hematoma and the other with an erythroblastic fetus. One neonate showed evidence of hemolysis 2 months postpartum that spontaneously improved. According to The Confidential Enquiry into Maternal and Child Health (CEMACH) reports in United Kingdom there are no maternal deaths due to Evans syndrome in last 10 years.
Association of Evans syndrome with pregnancy is a very rare disorder and it should be kept in mind for differential diagnosis in patients presenting with unexplained thrombocytopenia during pregnancy. Close follow up, early management, careful planning and preparation for delivery in such women would enhance the chances of a favorable outcome.
None
None
None
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
